Publicaciones en las que colabora con Juan Antonio Pineda Vergara (11)

2006

  1. Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients

    Journal of Clinical Microbiology, Vol. 44, Núm. 12, pp. 4455-4458

2004

  1. Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parenterally transmitted infections: Relationship between polymerase chain reaction results and other Leishmania infection markers

    American Journal of Tropical Medicine and Hygiene, Vol. 70, Núm. 5, pp. 545-548

2002

  1. Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy

    Journal of Clinical Microbiology, Vol. 40, Núm. 3, pp. 762-767

  2. Leishmania infantum (Protozoa, Kinetoplastida): Transmission from infected patients to experimental animal under conditions that simulate needle-sharing

    Experimental Parasitology, Vol. 100, Núm. 1, pp. 71-74

  3. Leishmania spp infection in injecting drug users [6]

    Lancet

  4. The high sensitivity of a PCR-ELISA in the diagnosis of cutaneous and visceral leishmaniasis caused by Leishmania infantum

    Annals of Tropical Medicine and Parasitology, Vol. 96, Núm. 7, pp. 669-677

2001

  1. Diagnosis of infections with Leishmania infantum using PCR-ELISA

    Parasitology, Vol. 122, Núm. 6, pp. 607-615

  2. Evidence of increased risk for Leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 20, Núm. 5, pp. 354-357

  3. False-positive results of leishmanin skin test due to phenol-containing diluent

    Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 95, Núm. 2, pp. 173-174

  4. Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients

    Clinical Infectious Diseases, Vol. 32, Núm. 4, pp. 633-635

1998

  1. Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain

    Journal of Clinical Microbiology, Vol. 36, Núm. 9, pp. 2419-2422